You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Portable nanofluidic aptamer-SERS instrument for measurement of chemical exposure

    SBC: Biotex, Inc.            Topic: NIEHS

    DESCRIPTION (provided by applicant): Project Summary The goal of this NIH-SBIR Phase I proposal is to develop a new point-of-care (POC) detection platform and methodology for assessment of human exposure to hazardous environmental compounds in the bloodstream. Because the mechanisms of transport of such chemicals into the body, their differing stabilities, and elimination are difficult to model, i ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  2. Robust Peptide-Based Diagnostics of Botulinum Toxins

    SBC: LYNNTECH INC.            Topic: NIEHS

    DESCRIPTION (provided by applicant): The botulinum neurotoxins (BoNTs; A-G), secreted by the anaerobic bacterium Clostridium botulinum, are highly lethal microbial proteins with an extremely low half-lethal dose of only 1-3 ng/kg in humans. In other words,one hundredth of a milligram (10 g) of the toxin could be extremely fatal to an adult; lower doses can result in partial muscle paralysis. Of t ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  3. A Small Molecule Targeting Wnt Pathway for Treatment of Diabetic Retinopathy

    SBC: Charlesson, LLC            Topic: NEI

    DESCRIPTION (provided by applicant): Diabetic retinopathy (DR) is a common complication of diabetes and a leading cause of blindness. This sight-threatening condition has become a public health challenge in the US. Currently, there is no FDA- approved drugfor DR. Laser photocoagulation has remained the gold standard for the treatment of DR over the past two decades. However, laser therapy is usual ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Engineering of Human Corneal Endothelial Grafts

    SBC: BIOTISSUE HOLDINGS INC.            Topic: NEI

    DESCRIPTION (provided by applicant): The corneal endothelium plays a pivotal role in maintaining corneal transparency. Unlike other species, the human corneal endothelium is notorious for its limited proliferative capacity in vivo after injury, aging, andsurgery. Persistet corneal endothelial dysfunction leads to sight- threatening bullous keratopathy. Presently, the only solution to restore visio ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  5. Development Of An Eye Drop To Treat Presbyopia

    SBC: ENCORE VISION, INC.            Topic: NEI

    DESCRIPTION (provided by applicant): Encore Vision has identified an innovative treatment for Presbyopia. The aim of the proposed phase I studies is to develop a topical ocular formulation of our co-drug to achieve therapeutic levels of active agent in therabbit aqueous humor without adversely affecting cornea health and lens metabolism. Onset of Presbyopia leading to progressive loss of near visi ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Propofol in Exhaled Breath: Real-time Detection by Surface Acoustic Wave Sensors

    SBC: XHALE, INC.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Propofol endures as the most popular intravenous (IV) anesthetic due to several favorable characteristics. Anesthesia personnel customarily measure the concentrations in breath of many agents used during surgery including: molecular oxygen to prevent hypoxia, carbon dioxide to assure placement of an endotracheal tube in the trachea and adequate ventilation, and ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  7. A New Tool Kit for Whole-Genome Mapping and Complementation in Drosophila

    SBC: GENETIVISION CORPORATION            Topic: NIGMS

    DESCRIPTION (provided by applicant): The ultimate goal of this proposal is to generate, maintain, and distribute a new collection of duplication stocks that covers the entire euchromatic autosomal portion of the Drosophila melanogaster genome. Since this collection will represent a powerful new set of tools that will benefit virtually all Drosophila geneticists, it is likely that there will be a h ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  8. New Building Blocks for the Synthesis of Modified RNAs

    SBC: AM BIOTECHNOLOGIES, LLC            Topic: NIGMS

    DESCRIPTION (provided by applicant): Functional RNA molecules such as aptamers, siRNAs, miRNAs, and related compounds have enormous potential as human therapeutics and as tools for elucidating gene regulation in vivo. To reach this potential, such molecules must be highly potent and highly nuclease resistant. Unmodified RNAs typically do not meet these requirements. A variety of chemical modifica ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Development of Anti-OLAM Aptamers as Novel Analgesics

    SBC: Operational Techologies Corporation            Topic: NIGMS

    DESCRIPTION (provided by applicant): Development of Anti-OLAM Aptamers as Novel Analgesics The management of pain remains a major health care problem due to an incomplete understanding of pain mechanisms. TRPV1, a prominent member of the transient receptorpotential (TRP) family of ligand-gated ion channel, detects noxious chemical and physical stimuli in peripheral tissues. Both pharmacological an ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  10. DEVELOPMENT OF RATIOMETRIC IMAGING PROBE SYSTEM FOR MONITORING INFLAMMATION

    SBC: PROGENITEC INC            Topic: NIGMS

    DESCRIPTION (provided by applicant): Inflammation is a major unifying syndrome associated with a variety of injury and diseases. When severe, inflammatory diseases can endanger and even kill patients. Direct diagnosis of the extent of inflammatory responses is often made histological with an invasive biopsy. Furthermore, multiple biopsies are often required to assess the extent of inflammatory rea ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government